Kovack Advisors, Inc. Astrazeneca PLC Transaction History

Kovack Advisors, Inc.

$1.02 Billion
Q3 2025

A detailed history of Kovack Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Kovack Advisors, Inc. holds 2,730 shares of AZN stock, worth $243,242. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,730

Previous 2,906 6.06%

Holding current value

$243,242

Previous $203,000 2.96%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$68.72 - $82.11 $12,094 - $14,451	-176 Reduced 6.06%	2,730 $209,000
Q2 2025 Aug 04, 2025	BUY	$64.87 - $75.0 $324 - $375	5 Added 0.17%	2,906 $203,000
Q1 2025 May 06, 2025	BUY	$65.37 - $77.96 $189,638 - $226,161	2,901 New	2,901 $213,000
Q3 2024 Nov 05, 2024	SELL	$76.67 - $87.62 $14,490 - $16,560	-189 Reduced 6.18%	2,871 $223,000
Q2 2024 Aug 02, 2024	BUY	$66.81 - $80.83 $5,678 - $6,870	85 Added 2.86%	3,060 $238,000
Q1 2024 Apr 19, 2024	BUY	$61.03 - $69.57 $181,564 - $206,970	2,975 New	2,975 $201,000
Q2 2023 Jul 21, 2023	BUY	$69.91 - $75.81 $2,866 - $3,108	41 Added 1.39%	2,994 $214,000
Q1 2023 Apr 20, 2023	SELL	$63.15 - $71.6 $2,715 - $3,078	-43 Reduced 1.44%	2,953 $204,000
Q4 2022 Feb 22, 2023	BUY	$54.21 - $70.44 $162,413 - $211,038	2,996 New	2,996 $203,000
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $79,171 - $95,043	-1,336 Reduced 28.62%	3,332 $220,000
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $42,514 - $51,212	763 Added 19.54%	4,668 $309,000
Q4 2021 Jan 18, 2022	SELL	$54.02 - $63.83 $47,807 - $56,489	-885 Reduced 18.48%	3,905 $227,000
Q3 2021 Nov 03, 2021	BUY	$55.56 - $60.79 $22,057 - $24,133	397 Added 9.04%	4,790 $288,000
Q2 2021 Jul 29, 2021	BUY	$48.42 - $60.18 $4,842 - $6,018	100 Added 2.33%	4,393 $263,000
Q1 2021 May 04, 2021	BUY	$47.16 - $54.44 $202,457 - $233,710	4,293 New	4,293 $213,000

Others Institutions Holding AZN

# of Institutions

1,478

Shares Held

492M

Call Options Held

6.18M

Put Options Held

3.01M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $276B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Account

Kovack Advisors, Inc. Astrazeneca PLC Transaction History